Anplag 90mg 20 Tablets

Detail Description
Anplag Tablets Specification
Requires Prescription: Yes
Generic Name
-
Ticagrelor
Used For
-
Blood clots
-
Cardiovascular death reduction
-
Myocardial infarction (MI)
-
Stroke prevention in patients with ACS or prior MI
-
Stent thrombosis prevention post-ACS treatment
How it Works
Ticagrelor reversibly interacts with the platelet P2Y12 ADP receptor, preventing signal transduction and platelet activation. Its active metabolite has a similar potency.
Dosage
-
Ticagrelor (standard dosage as prescribed by a physician)
Side Effects
-
Very Common: Bleeding, hyperuricemia, dyspnea
-
Common: Dizziness, syncope, headache, gout, vertigo, hypotension, respiratory bleeding
-
Uncommon: Tumor bleeding, hypersensitivity (including angioedema), intracranial hemorrhage, eye/ear hemorrhage, confusion
Drug Interactions
Avoid with:
-
Strong CYP3A inhibitors: ketoconazole, clarithromycin, ritonavir, etc.
-
Strong CYP3A inducers: rifampin, phenytoin, phenobarbital
-
Aspirin doses >100 mg
-
Simvastatin/Lovastatin >40 mg
-
Monitor Digoxin levels when co-administered
Contraindications
-
History of intracranial hemorrhage
-
Active bleeding (e.g., peptic ulcer)
-
Hypersensitivity to ticagrelor or ingredients
-
Severe hepatic impairment
Precautions
-
Increases risk of bleeding
-
Avoid abrupt discontinuation unless essential
-
Use cautiously in patients with liver disease
Warnings
-
Dyspnea is a known side effect; usually mild and transient.
-
Discontinuation risk: Sudden stopping may increase the chance of MI, stroke, or death.
-
Hepatic impairment: Use with caution; limited data available.
Pregnancy
-
Consult your physician before use.
Storage
-
Store at room temperature
-
Protect from heat and direct light